µÎ°æºÎ¾Ï Ä¡·áÁ¦ ½ÃÀå - ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø : ¾à¹° Á¾·ùº°, À¯Åë ä³Îº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Head and Neck Cancer Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class, By Distribution Channel, By Region and Competition, 2020-2030F
»óǰÄÚµå : 1692312
¸®¼­Ä¡»ç : TechSci Research
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 185 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,511,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 5,500 £Ü 7,957,000
PDF and Excel (Multi-User License) help
PDF ¹× Excel º¸°í¼­¸¦ ±â¾÷ÀÇ ÆÀÀ̳ª ±â°ü¿¡¼­ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,000 £Ü 11,575,000
PDF and Excel (Custom Research License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù. 80½Ã°£ÀÇ ¾Ö³Î¸®½ºÆ® ŸÀÓÀÌ Æ÷ÇԵǾî ÀÖ°í Copy & Paste °¡´ÉÇÑ PPT ¹öÀüµµ Á¦°øµË´Ï´Ù. ªÀº Bespoke ¸®¼­Ä¡ ÇÁ·ÎÁ§Æ® ¼öÇà¿¡ ¸Â´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è µÎ°æºÎ¾Ï Ä¡·áÁ¦ ½ÃÀåÀº 2024³â 19¾ï 5,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È ¿¬Æò±Õ ¼ºÀå·ü(CAGR) 6.11%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 27¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾ÏÀº ¿©ÀüÈ÷ Àü ¼¼°è ¼ö¹é¸¸ ¸íÀÇ »ý¸íÀ» ¾Ñ¾Æ°¡´Â ¼¼°è º¸°ÇÀÇ Å« ¹®Á¦ÀÔ´Ï´Ù. ¿©·¯ Á¾·ùÀÇ ¾Ï Áß¿¡¼­µµ µÎ°æºÎ¾ÏÀº ƯÈ÷ º¹ÀâÇϰí Ä¡·á°¡ ¾î·Á¿î ¾ÏÀÔ´Ï´Ù. ±¸°­, ÀεÎ, ÈĵÎ, ºÎºñµ¿, ºñ°­¿¡ ¹ß»ýÇÏ´Â Á¾¾çÀ» Æ÷ÇÔÇϸç, ȯÀÚÀÇ »îÀÇ Áú¿¡ ½É°¢ÇÑ ¿µÇâÀ» ¹ÌÄ¡±â ¶§¹®¿¡ Àü¹®ÀûÀÎ Ä¡·á°¡ ÇÊ¿äÇÕ´Ï´Ù. ¼¼°è µÎ°æºÎ¾Ï Ä¡·áÁ¦ ½ÃÀåÀº Çõ½ÅÀûÀÎ Ä¡·á ¼Ö·ç¼ÇÀ» Á¦°øÇÔÀ¸·Î½á ÀÌ ÀÇ·á ¹®Á¦¸¦ ÇØ°áÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÌ ¾ÏÀº ÀÔ, ¸ñ, ¼º´ë, ºÎºñµ¿, ħ»ù µî »óºÎ È£Èí±â ¹× ¼ÒÈ­°üÀÇ ¿©·¯ ºÎÀ§¿¡¼­ ¹ß»ýÇÕ´Ï´Ù. ¾Ë·ÁÁø À§ÇèÀÎÀڷδ ´ã¹è¿Í ¾ËÄÚ¿Ã »ç¿ë, ÀÎÀ¯µÎÁ¾ ¹ÙÀÌ·¯½º(HPV) °¨¿°, ´Ù¾çÇÑ È­ÇÐÁ¦Ç° ¹× ÀÚ±Ø ¹°Áú¿¡ ´ëÇÑ ³ëÃâ µîÀÌ ÀÖ½À´Ï´Ù.

½ÃÀå °³¿ä
¿¹Ãø ±â°£ 2026-2030³â
½ÃÀå ±Ô¸ð : 2024³â 19¾ï 5,000¸¸ ´Þ·¯
½ÃÀå ±Ô¸ð : 2030³â 27¾ï 5,000¸¸ ´Þ·¯
CAGR : 2025-2030³â 6.11%
±Þ¼ºÀå ºÎ¹® ¸é¿ª¿ä¹ý
ÃÖ´ë ½ÃÀå ºÏ¹Ì

µÎ°æºÎ¾Ï Ä¡·áÁ¦ ½ÃÀåÀº Ä¡·á ¼º°úÀÇ °³¼±°ú ȯÀÚÀÇ »îÀÇ Áú Çâ»óÀ» À§ÇÑ Áö¼ÓÀûÀÎ ¿¬±¸°³¹ßÀÌ ½ÃÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÏ´Â ÁÖ¿ä ¿äÀÎÀº HPV °¨¿°À¸·Î ÀÎÇÑ µÎ°æºÎ¾Ï ¹ßº´·üÀÇ Áõ°¡, ƯÈ÷ ÀþÀº ÃþÀÇ ¹ßº´·ü Áõ°¡ÀÔ´Ï´Ù. »ýÁ¸À² Çâ»óÀ» À§Çؼ­´Â Á¶±â ¹ß°ß°ú È¿°úÀûÀÎ Ä¡·á°¡ ÇʼöÀûÀÔ´Ï´Ù. Á¤¹ÐÀÇ·á, ¸é¿ªÄ¡·á µî ÀÇ·á±â¼úÀÇ ¹ß´Þ·Î º¸´Ù È¿°úÀûÀÌ°í ºÎÀÛ¿ëÀÌ ÀûÀº Ç¥ÀûÄ¡·á¿Í °³Àκ° ¸ÂÃã Ä¡·á°èȹÀÌ °³¹ßµÇ°í ÀÖ½À´Ï´Ù. ¼ö¼ú, È­Çпä¹ý, ¹æ»ç¼± Ä¡·á¿Í °°Àº ÀüÅëÀûÀÎ Ä¡·á¹ýÀº ¸é¿ª¿ä¹ý(üũÆ÷ÀÎÆ® ¾ïÁ¦Á¦ µî)°ú Ç¥Àû Ä¡·áÁ¦(EGFR ¾ïÁ¦Á¦ µî)¿Í °°Àº »õ·Î¿î ´ë¾ÈÀ¸·Î º¸¿ÏµÇ°í ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå ÃËÁø¿äÀÎ

µÎ°æºÎ¾ÏÀÇ ¹ßº´·ü Áõ°¡

ÁÖ¿ä ½ÃÀå °úÁ¦:

³ôÀº ¹ßº´·ü

ÁÖ¿ä ½ÃÀå µ¿Çâ:

±â¼ú ¹ßÀü

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå COVID-19°¡ ¼¼°èÀÇ µÎ°æºÎ¾Ï Ä¡·áÁ¦ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ

Á¦5Àå ¼¼°èÀÇ µÎ°æºÎ¾Ï Ä¡·áÁ¦ ½ÃÀå Àü¸Á

Á¦6Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ µÎ°æºÎ¾Ï Ä¡·áÁ¦ ½ÃÀå Àü¸Á

Á¦7Àå À¯·´ÀÇ µÎ°æºÎ¾Ï Ä¡·áÁ¦ ½ÃÀå Àü¸Á

Á¦8Àå ºÏ¹ÌÀÇ µÎ°æºÎ¾Ï Ä¡·áÁ¦ ½ÃÀå Àü¸Á

Á¦9Àå ³²¹ÌÀÇ µÎ°æºÎ¾Ï Ä¡·áÁ¦ ½ÃÀå Àü¸Á

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ µÎ°æºÎ¾Ï Ä¡·áÁ¦ ½ÃÀå Àü¸Á

Á¦11Àå ½ÃÀå ¿ªÇÐ

Á¦12Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

Á¦13Àå ¼¼°èÀÇ µÎ°æºÎ¾Ï Ä¡·áÁ¦ ½ÃÀå : SWOT ºÐ¼®

Á¦14Àå Porter's Five Forces ºÐ¼®

Á¦15Àå °æÀï ±¸µµ

Á¦16Àå Àü·«Àû Á¦¾È

Á¦17Àå Á¶»ç ȸ»ç ¼Ò°³ ¹× ¸éÃ¥»çÇ×

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global Head and Neck Cancer Drugs Market was valued at USD 1.95 billion in 2024 and is projected to reach USD 2.75 billion by 2030, with a compound annual growth rate (CAGR) of 6.11% during the forecast period. Cancer remains a significant global health challenge, affecting millions of lives worldwide. Among the various cancer types, head and neck cancer is particularly complex and difficult to treat. It includes tumors that develop in the oral cavity, pharynx, larynx, paranasal sinuses, and nasal cavity, and can severely impact patients' quality of life, requiring specialized treatments. The global head and neck cancer drugs market plays a critical role in addressing this medical issue by providing innovative therapeutic solutions. This cancer type affects several components of the upper respiratory and digestive tracts, including the mouth, throat, voice box, sinuses, and salivary glands. Known risk factors include tobacco and alcohol use, human papillomavirus (HPV) infection, and exposure to various chemicals and irritants.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.95 Billion
Market Size 2030USD 2.75 Billion
CAGR 2025-20306.11%
Fastest Growing SegmentImmunotherapy
Largest MarketNorth America

The head and neck cancer drugs market is driven by ongoing research and development efforts aimed at improving treatment outcomes and enhancing patient quality of life. A key factor contributing to market growth is the rising incidence of head and neck cancer, particularly among younger individuals due to HPV infections. Early detection and effective treatment are essential for improving survival rates. Advances in medical technologies, such as precision medicine and immunotherapy, have led to the development of targeted therapies and personalized treatment plans, which are more effective and have fewer side effects. Traditional treatments like surgery, chemotherapy, and radiation therapy are being supplemented by newer options, such as immunotherapies (e.g., checkpoint inhibitors) and targeted therapies (e.g., EGFR inhibitors).

Key Market Drivers:

Increasing Incidence of Head and Neck Cancer

Head and neck cancer is a complex group of diseases that affect the oral cavity, throat, larynx, and nasal passages. This type of cancer significantly impacts patients' quality of life and has been steadily increasing in incidence worldwide. According to Global Cancer Statistics, head and neck cancer ranks as the third most common cancer globally, with 1.46 million new cases and 487,993 deaths, accounting for 7.6% of all cancer cases and 4.8% of cancer-related deaths globally. This growing burden, coupled with advancements in cancer treatments, is driving demand for innovative therapies. The market for head and neck cancer drugs is anticipated to experience significant growth as the healthcare sector prioritizes cancer care and patients increasingly seek effective treatment options. Risk factors for head and neck cancer include tobacco and alcohol use, HPV infection, and certain dietary habits. While smoking rates have declined, leading to a decrease in cancers related to the larynx, the rise in oropharyngeal cancers linked to HPV infection remains a concern.

Key Market Challenges:

High Incidence Rates

One of the primary challenges faced by the head and neck cancer drugs market is the high incidence of the disease. With cancers affecting the mouth, throat, and larynx among the most prevalent globally, the increased number of cases places significant pressure on healthcare systems. This rising incidence fuels demand for more effective treatments and medications.

Key Market Trends:

Technological Advancements

Technological advancements are playing a pivotal role in improving the diagnosis, treatment, and prognosis of head and neck cancer. These innovations are not only enhancing patient outcomes but also stimulating market growth. High-resolution imaging techniques such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) allow healthcare providers to detect and assess head and neck cancers with greater accuracy, facilitating early detection and timely intervention. Additionally, advances in genomics and proteomics have led to the identification of specific biomarkers associated with head and neck cancer. Biomarker-based tests enable early diagnosis and help develop personalized treatment plans tailored to individual patients. Telemedicine has also revolutionized healthcare delivery, allowing remote consultations and pathology reviews. This is especially important for head and neck cancer, as it enables specialists to provide expertise and collaborate in underserved or remote regions.

Key Market Players:

Report Scope:

This report segments the Global Head and Neck Cancer Drugs Market into the following categories, in addition to providing insights into industry trends:

By Drug Class:

By Distribution Channel:

By Region:

Competitive Landscape:

This section includes detailed analysis and profiles of major companies operating in the Head and Neck Cancer Drugs Market.

Available Customizations:

TechSci Research offers customization options for this market report, allowing adjustments based on specific company needs. Customization options include the profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Head and Neck Cancer Drugs Market

5. Global Head and Neck Cancer Drugs Market Outlook

6. Asia Pacific Head and Neck Cancer Drugs Market Outlook

7. Europe Head and Neck Cancer Drugs Market Outlook

8. North America Head and Neck Cancer Drugs Market Outlook

9. South America Head and Neck Cancer Drugs Market Outlook

10. Middle East and Africa Head and Neck Cancer Drugs Market Outlook

11. Market Dynamics

12. Market Trends & Developments

13. Global Head and Neck Cancer Drugs Market: SWOT Analysis

14. Porter's Five Forces Analysis

15. Competitive Landscape

16. Strategic Recommendations

17. About Us & Disclaimer

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â